Hepatitis C Virus
Transient-replication assay allows quantitation of hepatitis C viral RNA replication
Published in Hepatitis Weekly, December 19th, 2005
"Dicistronic, subgenomic hepatitis C virus (HCV) replicons were constructed containing sequences from JFH1, a genotype 2a strain, that also incorporated the firefly luciferase gene under the control of the HCV internal ribosome entry site element."
"Luciferase activity in Huh-7 cell extracts containing in vitro-transcribed subgenomic JFH1 RNA was monitored over a 72 h period to examine early stages of HCV replication in the absence of any selective pressure," wrote P. Targettadams and colleagues, Medical...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2005-12-19)
More Articles from Hepatitis Weekly
- Hepatitis B Virus
Hepatitis B virus DNA in blood donors is a possible indicator of active infection - Hepatitis C Therapy
Host sphingolipid biosynthesis is a target for hepatitis C virus therapy - Hepatitis C Therapy
Immunosuppression may be beneficial for liver transplantation in HCV-infected patients - Heptatitis C Virus
Alpha interferon inhibits translation mediated by hepatitis C virus genotypes - Apoptosis
Apoptosis-inducing ligand and receptors are involved in viral hepatic diseases - Cardiology
New findings in the area of cardiology described - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
